Wolverine Trading
IGMS

Wolverine Trading’s IGM Biosciences IGMS Stock Holding History

Wolverine Trading’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,000
Closed -$266K – 6316
2021
Q3 		$266K Buy
+4,000
New +$306K ﹤0.01% 4896
2021
Q2 		– Sell
-4,400
Closed -$330K – 6326
2021
Q1 		$330K Buy
+4,400
New +$401K ﹤0.01% 4339

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wolverine Trading's IGMS Position: Q4 2021 in Review

Wolverine Trading sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 4,160 shares — an estimated $276K sold.

Wolverine Trading first reported a position in IGMS in Q3 2021 and held it in 1 quarter. The position peaked at $276K in Q3 2021. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • Wolverine Trading reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 4,160 IGM Biosciences shares in Q4 2021, an estimated $276K.
  • Wolverine Trading first reported a position in IGM Biosciences in Q3 2021 and held it in 1 quarter.
  • Wolverine Trading's IGM Biosciences position peaked at $276K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.